HYDERABAD, India Dr. Reddy’s Labs has launched a treatment for organ transplant patients, the Indian generic drug maker said Friday.
Dr. Reddy’s launched tacrolimus capsules in the 0.5-mg, 1-mg and 5-mg strengths. The drug is an immune system suppressant used to prevent rejection of transplanted livers, kidneys and hearts.
Tacrolimus capsules are a generic version of Astellas’ Prograf. Prograf and generic versions had combined sales of around $955 million in the United States during the 12-month period ended in March, according to IMS Health.